S. 1830In Committee
Right to Treat Act
Authorize terminally ill patients to access personalized investigational treatments based on their own genetic and molecular profile
Plain-English overview
What this bill does
Authorize terminally ill patients to access personalized investigational treatments based on their own genetic and molecular profile
Key points
- Authorize personalized investigational treatments
Current status
Where it stands
Status
In Committee
Latest action
2026-03-19 — Committee on Health, Education, Labor, and Pensions. Hearings held.
Related context
Topics and policy areas
undefinedAdministrative law and regulatory proceduresCenters for Disease Control and Prevention (CDC)Department of Health and Human ServicesFood and Drug Administration (FDA)HealthHealth care coverage and accessNational Institutes of Health (NIH)